Value Based Care Intelligence
M

Medisolv

Medisolv sells quality measurement and reporting software to hospitals and health systems, and in November 2026 it launched Chart Abstraction Solutions, which pairs AI with its quality software and expert services. ENCOR for Abstracted Measures and ENCOR for Clinical Registries propose an answer for each supported data element and show the clinical evidence behind it from notes, medications, labs and procedures; abstractors review the evidence, resolve questions and make the final decision. Coverage starts with the SEP-1 sepsis bundle, Hospital Outpatient Quality Reporting, and heart, stroke and surgical registries from the National Cardiovascular Data Registry, the Society of Thoracic Surgeons and Get With The Guidelines, with psychiatric measures, eCQMs, MIPS and more registries planned for 2027. Hospitals can use the software with their own staff, buy Expert Abstraction Services, or combine them.

Value Maximizer forecasts a hospital's results and payment effects under the CMS Value Based Purchasing, HAC Reduction and Readmissions Reduction programs, fitting a model per measure and recomputing quarterly from public CMS files; Citizens Medical Center, War Memorial Hospital, Memorial Health Care Systems and Covenant Health are named users. Medisolv reports 96% gold level accuracy in a cardiovascular registry pilot and 50% to 80% less abstraction time across health system pilots. Physician Zahid Butt founded the Columbia, Maryland company in 1999, Dave Lucey is chief executive, and it bought Lilac Software and Health Elements AI in 2026. The ENCOR suite holds HITRUST i1 certification, and a separate business associate agreement governs patient data.

AI Health Index verifiedNovember 20, 2026
Compare Medisolv with other vendors
Founded
1999
Headquarters
Columbia, Maryland
Website
medisolv.com/
Categories
vbc-intelligence, clinical-summarization
Indexed Products
ENCOR for Abstracted Measures, ENCOR for Clinical Registries, Expert Abstraction Services, Value Maximizer, ModelIQ, Chart Abstraction Solutions
Buyer Segments
Hospitals and health systems, Quality reporting teams, Specialty registry programs, Clinical data abstractors, Value based care leaders
Assessment

Capability Axes

An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read

AI Capability
BB on AI CentralityThe model is the engine of a core module. The platform carries other value, but this capability does not exist without it.
Vendor Published

Two learned components carry core modules. In chart abstraction, the AI retrieves evidence from notes, medications, labs and procedures and proposes an answer for each measure or registry field, which is the capability Chart Abstraction Solutions was launched to sell. Value Maximizer fits a forecasting model per measure and hospital to project CMS program performance and payments, choosing among time series, regression and simpler methods.

Around them sits a long established quality reporting business of registry submission, dashboards and managed abstraction services that works without AI, so the platform has value beyond the models while those two modules do not exist without them.

BB on Autonomy and Oversight ModelThe oversight structure is described and one part is missing, commonly the threshold at which the system stops or what happens after it is wrong.
Vendor Published

Abstractors review the evidence, resolve questions and make the final decision on every data element, and in the managed service Medisolv's clinical abstractors validate results before submission. Hospitals choose whether their own staff or Medisolv's do that review. Value Maximizer's forecasts are planning views, refreshed quarterly with a report of what changed. The structure is clear about who decides. What is missing is any threshold: when the AI declines to suggest an answer, how an ambiguous case is escalated, and whether low confidence suggestions are marked differently from strong ones.

BB on Model and Technology TransparencyThe approach or the suppliers are named without the version and update discipline behind them. Naming a supplier is the entry to this band both here and on Model Supply Chain Disclosure, which ask different questions of the same disclosure: who receives the data, and what produces the output.
Vendor Published

Value Maximizer's method is set out in detail: each quarter it fits a model per hospital, measure and provider, choosing among time series, simple linear regression, a mean or the latest value carried forward until it finds the best fit, using CMS Care Compare files, QualityNet benchmarks and final IPPS rule parameters, and it measures accuracy as mean absolute error. Abstraction suggestions are grounded in chart evidence shown beside each answer. The models behind abstraction, their training data, the technology brought in with Health Elements AI and how versions change for each registry are not described.

CC on Model Supply Chain DisclosureThe architecture is described and no model provider is named. Naming a hosting provider alone does not lift a record out of this band. Record the host in the note, because it matters for residency and breach scope, and grade on the model layer, which is the question this axis is named for.
Vendor Published

Value Maximizer runs on public CMS data with no patient level detail and Medisolv's own forecasting methods. Abstraction is the path that touches patient charts, and part of it rests on technology acquired with Health Elements AI.

The universal terms let Medisolv use approved hosting and services subcontractors and hold it responsible for them, but no subprocessor list or model provider is named, so whether chart data reaches an outside model service, and on what retention and training terms, is unknown. The cloud host for ENCOR is not named either.

BB on Clinical and Operational EvidenceNamed deployments with dated outcome figures and enough method to test them, or published research short of independent validation.
Vendor Published

Medisolv reports 96% gold level accuracy in a cardiovascular registry pilot and 50% to 80% less abstraction time across evaluated health system pilots, figures released with the November 2026 launch. An unnamed academic medical center reports greater than 96% accuracy and 68% less abstraction time. None of the pilot sites is named, and no sample size, period or adjudication method is given beyond the gold level comparison.

Value Maximizer has named users, Citizens Medical Center, War Memorial Hospital, Memorial Health Care Systems and Covenant Health, with testimonials but no measured outcomes, and its forecast error is available only on request.

CC on AI Safety and PHI StewardshipGeneral assurances of privacy and security that do not answer the questions artificial intelligence raises: what is retained, what reaches a model, and what happens to it there.
Vendor Published

Abstraction draws on notes, vital signs, medications, labs and procedures, and the clinical evidence for each suggestion is shown to the abstractor. The universal terms treat patient information as confidential, govern protected health information through a separately signed business associate agreement, and provide for transfer assistance and the return or unrecoverable destruction of confidential material at termination.

Value Maximizer uses facility level CMS files with no patient level detail. How long chart data is kept in the AI workflow, whether it trains the abstraction models, how it is deidentified, and how a model error is handled are not stated.

Regulatory and Compliance
BB on HIPAA and BAA PostureBusiness associate status is stated and supported by a substantive privacy document, with the agreement or its scope not fully published. For a vendor outside the United States, an equivalent regime documented to this depth grades here. A vendor whose product does not process protected health information grades here too when it says so plainly and explains the scope, with a service privacy document behind it: stating a position a buyer can rely on is the posture this axis grades, and the band above is closed to it because there is no agreement to publish.
Vendor Published

Medisolv's universal terms state that it acts as a business associate for protected health information in client records, that the client keeps ownership of that information, and that its use and disclosure follow a separate agreement signed by both parties. The terms bind personnel, subcontractors and hosting sites to confidentiality and give the client rights over offshore hosting.

The business associate agreement itself is not published, so its tier provisions and the language extending its obligations to subcontractors cannot be read before contracting, though the status and the governing document are both clear.

BB on Security Certifications and Trust CenterA recognized certification is named in the vendor own material without the artifact, or with a scope or renewal question the buyer has to raise. A recognized certification here is an audit of how the vendor operates security, such as SOC 2, HITRUST or ISO/IEC 27001. A certification has a scope and a clock, and both are part of this grade. A certification the vendor attaches to its data center, hosting facility or cloud provider, rather than presenting as its own, is the host's and does not count here.
Vendor Published

HITRUST i1 certification, announced in 2026, covers the ENCOR quality management suite and its clinical workflow environment. The i1 is HITRUST's mid level assessment and is renewed yearly. The universal terms add secure cloud hosting with separate primary and backup sites, infrastructure responsibilities, confidentiality duties for personnel and subcontractors, and controls on offshore hosting.

No certificate, report or trust center opens without a request, and whether the AI abstraction features launched in November 2026, or the acquired Lilac Software and Health Elements AI products, fall inside the certified scope is not stated.

CC on FDA and Regulatory StatusNo device claim is made and the product is scoped accordingly. Most administrative and operational products sit here and are not penalized for it, because this axis grades the appropriateness of the positioning rather than possession of a clearance. A stated limit on use, such as research use only or a clause that the product gives no medical advice, beside marketing that sells the product for clinical decisions also sits here, with both quoted, because the buyer has to ask which one governs.
Vendor Published

The products prepare clinical data for quality reporting, registries and hospital payment programs: abstraction suggests registry and measure fields for an abstractor to confirm, and Value Maximizer projects facility level performance and payments from CMS files. Neither makes a diagnosis or treatment decision for a patient, and registry submission certification concerns acceptance of the reporting workflow rather than a clinical indication.

The 2027 roadmap adds psychiatric measures and eCQM support, which stay within the same reporting purpose. Medisolv makes no device claim, and the scope it sells, measurement and administrative reporting, matches that position.

BB on AI Governance and Bias DisclosureA governance framework with named process behind it, such as certification to an artificial intelligence management standard, or material written for a customer own review committee to evaluate the product with. A framework covering the vendor whole portfolio counts when its scope reaches this product; what it cannot supply is the product specific evaluation the band above asks for. Published results within the one group where the performance of this product is most at risk also sit here: evaluation on the question this axis asks, short of the comparison across groups the band above requires. A medical device clearance or certification, and the quality system behind it, does not reach this band on its own; it is graded under regulatory status. A regulator reviewed plan governing how the model may change does reach it.
Vendor Published

Every suggested answer carries its evidence trail, abstractors make the final decision, and in the managed service clinical abstractors validate the AI's results and manage the process. The cardiovascular registry pilot measured the output against gold level abstraction, and Value Maximizer's forecast error is tracked as mean absolute error, available on request. Those give a quality team material to review the tools with.

No results show how abstraction accuracy differs across hospitals, documentation styles, registries or patient groups, and no independent review of the models is named, so governance rests on process and a single pilot comparison.

BB on AI Liability and RecourseA published falsifiable commitment, or a real correction route the affected person can exercise against the vendor. A published error rate with its method and denominator grades here. A statutory right that runs to the covered entity rather than to the vendor does not reach this band on its own: every other route here asks something of the vendor, and being located in a particular jurisdiction is not conduct.
Vendor Published

Every proposed answer can be checked against the chart evidence shown beside it and changed before it is finalized. The universal terms warrant conformity to the applicable specifications, require a cure at no cost within 30 days of qualifying notice or allow termination with a prorated refund, and provide mutual indemnity for specified acts, errors, omissions and breaches, with a general cap tied to fees paid and payable.

Those protections attach to the service conforming to its specifications. No warranty addresses whether a particular AI suggested registry value is correct, so a wrong submission remains the hospital's to catch.

Integration and Deployment
BB on EHR and Interoperability DepthNamed systems with read access or one directional writing, or standards support with named deployments behind it.
Vendor Published

Finished abstractions submit from ENCOR to quality reporting entities and registries, including CMS, the National Cardiovascular Data Registry, the Society of Thoracic Surgeons and Get With The Guidelines, and an academic center describes submitting to several of them from one workflow. On the input side, abstraction reads the clinical chart, and an ENCOR license adds encounter and provider detail to Value Maximizer. Which EHRs feed the chart data, and how, is not named, and no customer is shown with a two way connection between its record system and ENCOR.

BB on Deployment Model and Data ResidencyOptions and residency are stated with isolation or the processing path left open.
Vendor Published

ENCOR runs as a cloud service on secure infrastructure with separate primary and backup sites, and the universal terms require Medisolv's prior written approval before client data is hosted outside the United States, with a right to terminate if an unapproved offshore move is not fixed. Medisolv answers for its hosting providers and supports an orderly transfer after termination. Some ENCOR clients also run an on premises dashboard of selected measures. Which cloud provider and regions run the AI abstraction, and how customers are isolated from each other, are not stated.

Commercial
CC on Commercial TransparencyNo price is published and the posture is discoverable: a buyer can establish how the product is sold and what drives the cost before contacting the vendor. Most of the index sits here.
Vendor Published

Annual subscriptions under an agreement are the model, with professional services added by work order on a fixed fee or time and materials basis. For abstraction a hospital can license ENCOR for its own staff, buy Expert Abstraction Services for defined workloads, or combine them, and Value Maximizer comes with guided implementation, multi hospital licenses that add corporate reports, and an extra ENCOR license for encounter and provider detail. No price is shown for any product, and whether abstraction is charged by abstraction, measure, registry or facility is not stated, so the structure is clear while the amounts are not.

BB on Setting and Specialty CoverageCoverage is named with validation behind part of it.
Vendor Published

Hospital quality managers and clinical abstractors are the users, across abstracted measures such as SEP-1 and outpatient quality reporting and heart, stroke and surgical registries from NCDR, STS and Get With The Guidelines. Value Maximizer serves hospital teams planning for the CMS Value Based Purchasing, HAC Reduction and Readmissions Reduction programs.

The cardiovascular registry pilot validates part of the abstraction coverage, while sepsis, outpatient, stroke and surgical results are not reported separately. Psychiatric, eCQM, MIPS and further registry coverage is planned for 2027 rather than offered today.

Alternatives

Alternatives to Medisolv

Other products that do the same kind of work as Medisolv, and what each one does.

Carta Healthcare supplies software and clinical abstraction services for hospital registry teams. Lighthouse reads patient records and proposes answers to registry questions, with supporting passages and links to the original clinical documents.

AccuCode AI, founded in 2023 in Little Rock, Arkansas, with a second office in Seattle, runs autonomous medical coding and clinical quality abstraction on one engineering stack.

Layer Health is a Massachusetts Institute of Technology spin out, founded in 2023 and based in Boston, applying large language models to clinical chart review.

Astrata reads clinical charts so quality teams do not have to. The company builds natural language processing for healthcare quality measurement, aimed at the HEDIS reporting that determines health plan star ratings and quality bonus payments.

Reveleer is a Glendale, California company founded in 2009 as a medical record retrieval business and since rebuilt as a value based care platform for health plans and risk bearing providers across Medicare Advantage, ACA Marketplace and Medicaid.

COZEVA is a cloud platform for health plans and provider organizations that manage quality, risk adjustment and cost under value based contracts.

Commercial

Pricing

Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.

Entry Price Pricing Basis BAA Tier Implementation Source
Contact sales
Medisolv sells annual subscriptions under an agreement, with no prices shown. Value Maximizer encounter and provider detail requires an additional ENCOR license. The universal terms state that Medisolv acts as a business associate, with protected health information governed by a separately signed business associate agreement. Value Maximizer comes with guided implementation. Other professional services are set by work order on a fixed fee or time and materials basis. Vendor Published

Hospitals can license AI assisted abstraction software for their own staff, buy Expert Abstraction Services for defined workloads, or combine the two. Subscription scope and the price of contracted abstraction are set in the agreement.